Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000524605 | SCV000644287 | pathogenic | Tuberous sclerosis 2 | 2017-01-26 | criteria provided, single submitter | clinical testing | Loss-of-function variants in TSC2 are known to be pathogenic. This particular variant has been reported in individuals affected with tuberous sclerosis complex (TSC), in the literature (PMID: 25782670) and in the Leiden Open-source Variation Database (PMID: 21520333). For these reasons, this variant has been classified as Pathogenic. This sequence change affects a donor splice site in intron 17 of the TSC2 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. |